The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Stalevo



Orion CorporationEU/1/03/260/009-012,15,18

Main Information

Trade NameStalevo
Active Substances
Dosage FormNot assigned
Licence HolderOrion Corporation
Licence NumberEU/1/03/260/009-012,15,18

Group Information

ATC CodeN04BA Dopa and dopa derivatives
N04BA03 levodopa, decarboxylase inhibitor and COMT inhibitor

Status

License statusAuthorised
Licence Issued
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back